Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in iTeos Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
144
0 vs. Q2 2023
Shares held
35.5M
+866.2K (+2.5%) vs. Q2 2023
Total value
$388.6M
−$69.9M (−15.2%) vs. Q2 2023
New holders
15
58 more added
Sold out
15
48 more reduced

2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 144 institutions
Q1 2021: 81 institutionsQ2 2021: 83 institutionsQ3 2021: 77 institutionsQ4 2021: 118 institutionsQ1 2022: 159 institutionsQ2 2022: 153 institutionsQ3 2022: 143 institutionsQ4 2022: 146 institutionsQ1 2023: 153 institutionsQ2 2023: 146 institutionsQ3 2023: 144 institutionsQ4 2023: 138 institutionsQ1 2024: 136 institutionsQ2 2024: 139 institutionsQ3 2024: 151 institutionsQ4 2024: 137 institutionsQ1 2025: 132 institutionsQ2 2025: 137 institutionsQ3 2025: 1 institutionQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $388.6M
Q1 2021: $1.03BQ2 2021: $755.8MQ3 2021: $841.3MQ4 2021: $1.55BQ1 2022: $1.17BQ2 2022: $768.1MQ3 2022: $698.2MQ4 2022: $707.3MQ1 2023: $488.9MQ2 2023: $460.4MQ3 2023: $388.6MQ4 2023: $383.4MQ1 2024: $471.2MQ2 2024: $536.8MQ3 2024: $373.3MQ4 2024: $262.2MQ1 2025: $220.7MQ2 2025: $377.0MQ3 2025: $2.35KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ITOS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20251$2.35K
Q2 2025137$377.0M
Q1 2025132$220.7M
Q4 2024137$262.2M
Q3 2024151$373.3M
Q2 2024139$536.8M
Q1 2024136$471.2M
Q4 2023138$383.4M
Q3 2023144$388.6M
Q2 2023146$460.4M
Q1 2023153$488.9M
Q4 2022146$707.3M
Q3 2022143$698.2M
Q2 2022153$768.1M
Q1 2022159$1.17B
Q4 2021118$1.55B
Q3 202177$841.3M
Q2 202183$755.8M
Q1 202181$1.03B

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding ITOS in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Victory Capital Management Inc99,133$1.09M0.00%+351+0.4%Added
Octagon Capital Advisors LP102,000$1.12M0.20%−494,000−82.9%Reduced
Bank of America Corp103,475$1.13M0.00%−12,389−10.7%Reduced
Los Angeles Capital Management LLC105,554$1.16M0.00%−4,468−4.1%Reduced
Readystate Asset Management LP105,691$1.16M0.10%+17,300+19.6%Added
Empowered Funds, LLC110,310$1.21M0.04%+9,006+8.9%Added
D. E. Shaw & Co., Inc.114,458$1.25M0.00%+34,976+44.0%Added
Ameriprise Financial Inc133,219$1.46M0.00%−215−0.2%Reduced
FMR LLC140,663$1.54M0.00%−540.0%Reduced
Panagora Asset Management Inc146,276$1.60M0.01%+25,237+20.9%Added
Baker Bros. Advisors LP150,346$1.65M0.01%00.0%Unchanged
Principal Financial Group Inc152,342$1.67M0.00%+5,555+3.8%Added
Sectoral Asset Management Inc155,075$1.70M0.33%+8,499+5.8%Added
Vontobel Holding Ltd.155,075$1.70M0.02%+8,499+5.8%Added
Bridgeway Capital Management, LLC176,810$1.94M0.05%+9,006+5.4%Added
Invesco Ltd.207,165$2.27M0.00%−8,202−3.8%Reduced
Charles Schwab Investment Management Inc210,171$2.30M0.00%+19,258+10.1%Added
Prudential Financial Inc251,701$2.76M0.00%−39,350−13.5%Reduced
Morgan Stanley261,753$2.87M0.00%+85,073+48.2%Added
Northern Trust Corp277,235$3.04M0.00%+10,397+3.9%Added
Bank of New York Mellon Corp278,959$3.05M0.00%+17,090+6.5%Added
Barclays PLC322,322$3.53M0.00%+7,442+2.4%Added
Ikarian Capital, LLC346,471$3.79M1.41%+346,471New
Renaissance Technologies LLC394,000$4.31M0.01%−19,200−4.6%Reduced
Artal Group S.A.400,000$4.38M0.19%00.0%Unchanged
Jacobs Levy Equity Management, Inc459,712$5.03M0.03%−30,668−6.3%Reduced
Janus Henderson Group PLC500,324$5.48M0.00%+500,324New
Candriam Luxembourg S.C.A.511,537$5.60M0.05%−100,010−16.4%Reduced
Geode Capital Management, LLC532,087$5.83M0.00%+30,075+6.0%Added
Goldman Sachs Group Inc609,212$6.67M0.00%−34,453−5.4%Reduced
Dimensional Fund Advisors LP700,953$7.68M0.00%+122,304+21.1%Added
Deerfield Management Company, L.P. (Series C)723,000$7.92M0.17%+723,000New
683 Capital Management, LLC810,000$8.87M0.90%+225,000+38.5%Added
Saturn V Capital Management LLC994,756$10.9M4.56%+358,598+56.4%Added
Citadel Advisors LLC1,007,572$11.0M0.01%−187,697−15.7%Reduced
Millennium Management LLC1,032,846$11.3M0.01%+206,744+25.0%Added
BVF Inc1,259,476$13.8M0.37%−551,359−30.4%Reduced
State Street Corp1,581,493$17.3M0.00%+16,291+1.0%Added
MPM Oncology Impact Management LP1,745,943$19.1M5.10%00.0%Unchanged
Boxer Capital, LLC1,804,058$19.8M1.05%−350,000−16.2%Reduced
Vanguard Group Inc1,813,759$19.9M0.00%+40,407+2.3%Added
MPM Asset Management LLC2,738,785$30.0M16.06%00.0%Unchanged
Ra Capital Management, L.P.4,417,259$48.4M0.95%00.0%Unchanged
BlackRock Inc.5,050,968$55.3M0.00%+370,774+7.9%Added
Bank of Montreal0$00.00%−171,389−100.0%Sold out
AlphaCentric Advisors LLC0$00.00%−63,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−35,429−100.0%Sold out
ClariVest Asset Management LLC0$00.00%−35,255−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−16,413−100.0%Sold out
Franklin Resources Inc0$00.00%−12,072−100.0%Sold out
Simplex Trading, LLC0$00.00%−11,503−100.0%Sold out
Worth Venture Partners, LLC0$00.00%−10,900−100.0%Sold out
Group One Trading, L.P.0$00.00%−7,321−100.0%Sold out
C M Bidwell & Associates Ltd0$00.00%−3,929−100.0%Sold out
KBC Group NV0$00.00%−1,773−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,400−100.0%Sold out
Parallel Advisors, LLC0$00.00%−227−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−162−100.0%Sold out
25 LLC0$00.00%−34−100.0%Sold out
EA Series Trust––––Not filed
Tekla Capital Management LLC––––Not filed